Haemonetics (HAE) EBT Margin (2009 - 2026)
Haemonetics' quarterly EBT Margin came in at 8.2% in Q1 2026, down 2960.0% year-on-year from 0.29% in Q1 2025, and down 146.34% quarter-over-quarter from 17.69% in Q4 2025.
Haemonetics has reported EBT Margin for 18 years, with the latest figure at 8.2% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 2960.0% year-over-year to 8.2%; the trailing twelve-month figure through Mar 2026 stood at 9.6% (down 599.0% YoY), and the FY2026 full-year result was 9.6%, down 599.0% from the prior year.
- EBT Margin for Q1 2026 stood at 8.2%, down from 17.69% in the prior quarter.
- The five-year high for EBT Margin was 21.4% in Q1 2025, with the low at 8.2% in Q1 2026.
- Average EBT Margin over 5 years is 11.92%, with a median of 13.45% recorded in 2022.
- Year-over-year, EBT Margin soared 1796 bps in 2022 and plunged 2960 bps in 2026.
- Tracing HAE's EBT Margin over 5 years: stood at 13.83% in 2022, then dropped by 5 bps to 13.09% in 2023, then rose by 9 bps to 14.32% in 2024, then gained by 24 bps to 17.69% in 2025, then slumped by 146 bps to 8.2% in 2026.
- The last three EBT Margin figures came in at 8.2% (Q1 2026), 17.69% (Q4 2025), and 15.67% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Haemonetics | 3.18 Bn | 2.93 Bn | 198.21 Mn | -8.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -8.20% |
| Dec 27, 2025 | 17.69% |
| Sep 27, 2025 | 15.67% |
| Jun 28, 2025 | 14.05% |
| Mar 29, 2025 | 21.40% |
| Dec 28, 2024 | 14.32% |
| Sep 28, 2024 | 12.94% |
| Jun 29, 2024 | 13.90% |
| Mar 30, 2024 | 6.82% |
| Dec 30, 2023 | 13.09% |
| Sep 30, 2023 | 10.32% |
| Jul 1, 2023 | 16.57% |
| Apr 1, 2023 | 10.72% |
| Dec 31, 2022 | 13.83% |
| Oct 1, 2022 | 13.80% |
| Jul 2, 2022 | 9.75% |
| Apr 2, 2022 | 5.78% |
| Jan 1, 2022 | 12.08% |
| Oct 2, 2021 | 8.30% |
| Jul 3, 2021 | -1.32% |
| Apr 3, 2021 | -12.17% |
| Dec 26, 2020 | 15.55% |
| Sep 26, 2020 | 26.23% |
| Jun 27, 2020 | 4.08% |
| Mar 28, 2020 | 9.21% |
| Dec 28, 2019 | 14.61% |
| Sep 28, 2019 | 17.85% |
| Jun 29, 2019 | -7.43% |
| Mar 30, 2019 | 8.75% |
| Dec 29, 2018 | 10.29% |
| Sep 29, 2018 | 9.54% |
| Jun 30, 2018 | 1.45% |
| Mar 31, 2018 | 5.70% |
| Dec 30, 2017 | 0.09% |
| Sep 30, 2017 | 10.14% |
| Jul 1, 2017 | 11.02% |
| Apr 1, 2017 | -25.95% |
| Dec 31, 2016 | 8.31% |
| Oct 1, 2016 | 10.37% |
| Jul 2, 2016 | -4.79% |
| Apr 2, 2016 | -3.41% |
| Dec 26, 2015 | -27.13% |
| Sep 26, 2015 | 7.54% |
| Jun 27, 2015 | 0.75% |
| Mar 28, 2015 | 4.26% |
| Dec 27, 2014 | 6.88% |
| Sep 27, 2014 | 4.29% |
| Jun 28, 2014 | -1.87% |
| Mar 29, 2014 | 4.05% |
| Dec 28, 2013 | 6.20% |
| Sep 28, 2013 | 8.86% |
| Jun 29, 2013 | -4.21% |
| Mar 30, 2013 | 5.88% |
| Dec 29, 2012 | 5.34% |
| Sep 29, 2012 | 3.94% |
| Jun 30, 2012 | 7.60% |
| Mar 31, 2012 | 11.43% |
| Dec 31, 2011 | 13.32% |
| Oct 1, 2011 | 10.59% |
| Jul 2, 2011 | 13.89% |
| Apr 2, 2011 | 16.80% |
| Jan 1, 2011 | 15.82% |
| Oct 2, 2010 | 17.48% |
| Jul 3, 2010 | 14.95% |
| Apr 3, 2010 | 2.30% |
| Dec 26, 2009 | 15.36% |
| Sep 26, 2009 | 16.60% |
| Jun 27, 2009 | 16.83% |